Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer Anand G. PatilRussell D’SouzaAnagha Damre Short Communication 02 July 2011 Pages: 115 - 119
Explicit reformulations of the Lambert W-omega function for calculations of the solutions to one-compartment pharmacokinetic models with Michaelis–Menten elimination kinetics Marko Goličnik Original Paper 01 May 2011 Pages: 121 - 127
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor Kan HeJoseph M. LuettgenScott J. Grossman Original Paper 02 April 2011 Pages: 129 - 139
Renal excretion of apricitabine in rats: ex vivo and in vivo studies Mariana BabayevaSusan CoxDavid R. Taft Original Paper 06 April 2011 Pages: 141 - 150
Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum Erin MilnerJason SousaGeoffrey Dow Original Paper 13 July 2011 Pages: 151 - 158
In vitro characterization of rosiglitazone metabolites and determination of the kinetic parameters employing rat liver microsomal fraction Leandro Augusto CalixtoAnderson Rodrigo Moraes de OliveiraPierina Sueli Bonato Original Paper 17 April 2011 Pages: 159 - 166
Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis Franciszek GłówkaMarta Karaźniewicz-ŁadaWojciech Romanowski Original Paper Open access 24 April 2011 Pages: 167 - 173
Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats Cheng LiSung-Cil LimJun-Shik Choi Original Paper 27 March 2011 Pages: 175 - 182
One-compartmental biometric blood loss calculation after cesarean section Natasa MilosevicJovan PopovicMilan Rapaic Original Paper 08 May 2011 Pages: 183 - 188